Related Experiment Video
Updated: Dec 6, 2025

08:05
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
952
Driverless artificial intelligence framework for the identification of malignant pleural effusion.
Yuan Li1, Shan Tian2, Yajun Huang3
1Department of Oncology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei 430060, China.
Translational Oncology
|October 12, 2020
Summary
This study shows that artificial intelligence (AI) models, particularly gradient boosting machine (GBM), can effectively distinguish malignant pleural effusion (MPE) from benign pleural effusion (BPE) using routine clinical data.
Area of Science:
- Medical Artificial Intelligence
- Machine Learning in Medicine
- Diagnostic Accuracy
Background:
- Distinguishing malignant pleural effusion (MPE) from benign pleural effusion (BPE) is clinically challenging.
- Accurate differentiation is crucial for appropriate patient management and treatment strategies.
Purpose of the Study:
- To evaluate the efficacy of deep learning (DL) and machine learning (ML) models in differentiating MPE from BPE.
- To assess the external validity of these predictive models.
Main Methods:
- Utilized a retrospective cohort of 726 patients with pleural effusion (PE) for model training and testing.
- Employed driverless AI, DL, and five ML models: GBM, XGBoost, XRT, DRF, and GLM.
- Validated the models using a prospective cohort of 172 PE patients.
Main Results:
- The stacked ensemble AI model achieved high diagnostic performance with Area Under the Curve (AUC) of 0.991 (training), 0.912 (test), and 0.953 (validation).
- Gradient Boosting Machine (GBM) demonstrated robust and consistent predictive efficiency across all datasets.
- While DL excelled in the training set (AUC=0.995), GBM showed superior stability in external validation.
Conclusions:
- Driverless AI, leveraging routinely collected clinical data, significantly enhances diagnostic performance for MPE vs. BPE.
- Machine learning models, especially GBM, offer a promising and reliable approach for pleural effusion classification.
- The developed AI framework holds potential for improving clinical decision-making in diagnosing pleural effusions.
Related Concept Videos
Pleural Effusion I: Introduction
3.2K
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
3.2K
Pleural Effusion II: Symptoms and Management
452
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
452

